Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:

Human brain organoid techniques have rapidly advanced to facilitate investigating human brain development and diseases. These efforts have largely focused on generating telencephalon due to its direct relevance in a variety of forebrain disorders. Despite its importance as a relay hub between cortex and peripheral tissues, the investigation of three-dimensional (3D) organoid models for the human thalamus has not been explored. Here, we describe a method to differentiate human embryonic stem cells (hESCs) to thalamic organoids (hThOs) that specifically recapitulate the development of thalamus. Single-cell RNA sequencing revealed a formation of distinct thalamic lineages, which diverge from telencephalic fate. Importantly, we developed a 3D system to create the reciprocal projections between thalamus and cortex by fusing the two distinct region-specific organoids representing the developing thalamus or cortex.Our study provides a platform for understanding human thalamic development and modeling circuit organizations and related disorders in the brain.(C) qPCR analysis for expressions of regional markers in developing hThOs, hMGEOs, and hCOs. Each data point represents expressions in pooled batch of 3-4 organoids, and 3 batches were collected for analysis. Mean ± SD is shown. *p < 0.05, **p < 0.01, ***p < 0.001. (D) Immunostaining for MAP2 and thalamic marker TCF7L2 in day 41 hThO, hCO, and hMGEO. The scale bar represents 250 mm. (E) Immunostaining for thalamic and cortical progenitor marker PAX6, and cortical marker TBR1 in day 41 hThO, hCO, and hMGEO. The scale bar represents 250 mm. See also Figure S1.

SummaryIn this study, human embryonic stem cell-derived hepatocytes (hESC-Heps) were investigated for their ability to support hepatitis C virus (HCV) infection and replication. hESC-Heps were capable of supporting the full viral life cycle, including the release of infectious virions. Although supportive, hESC-Hep viral infection levels were not as great as those observed in Huh7 cells. We reasoned that innate immune responses in hESC-Heps may lead to the low level of infection and replication. Upon further investigation, we identified a strong type III interferon response in hESC-Heps that was triggered by HCV. Interestingly, specific inhibition of the JAK/STAT signaling pathway led to an increase in HCV infection and replication in hESC-Heps. Of note, the interferon response was not evident in Huh7 cells. In summary, we have established a robust cell-based system that allows the in-depth study of virus-host interactions in vitro.